Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II 'selective' inhibitor celecoxib

被引：87

作者：

Di Fiore, A

Pedone, C

D'Ambrosio, K

Scozzafava, A

De Simone, G

Supuran, CT

机构：

[1] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy

[2] Univ Naples Federico II, Dipartimento Sci Biol, Sez Biostrutture, I-80134 Naples, Italy

[3] Univ Florence, Polo Sci, Lab Chim Bioinorgan, I-50019 Sesto Fiorentino, Florence, Italy

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 02期

关键词：

carbonic anhydrase; isoform II; X-ray crystallography; sulfonamide; valdecoxib; celecoxib; acetazolamide; COX-2 selective inhibitors;

D O I：

10.1016/j.bmcl.2005.09.040

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The high resolution X-ray crystal structure of the adduct of human carbonic anhydrase (CA, EC 4.2.1.1) isoform II (hCA II) with the clinically used painkiller valdecoxib, acting as a potent CA II and cyclooxygenase-2 (COX-2) inhibitor, is reported. The ionized sulfonamide moiety of valdecoxib is coordinated to the catalytic Zn(II) ion with a tetrahedral geometry. The phenyl-isoxazole moiety of the inhibitor fills the active site channel and interacts with the side chains of Gln92, Vall21, Leu198, Thr200, and Pro202. Its 3-phenyl group is located into a hydrophobic pocket, simultaneously establishing van der Waals interactions with the aliphatic side chain of various hydrophobic residues (Val135, Ile91, Vall21, Leu198, and Leu141) and a strong offset face-to-face stacking interaction with the aromatic ring of Phe131 (the chi 1 angle of which is rotated of about 90 degrees with respect to what was observed in the structure of the native enzyme and those of other sulfonamide complexes). Celecoxib, a structurally related COX-2 inhibitor for which the X-ray crystal structure was reported earlier, binds in a completely different manner to hCA II as compared to valdecoxib. Celecoxib completely fills the entire CA II active site, with its trifluoromethyl group in the hydrophobic part of the active site and the p-tolyl moiety in the hydrophilic one, not establishing any interaction with Phe131. In contrast to celecoxib, valdecoxib was rotated about 90 degrees around the chemical bond connecting the benzensulfonamide and the substituted isoxazole ring allowing for these multiple favorable interactions. These different binding modes allow for the further drug design of various CA inhibitors belonging to the benzenesulfonamide class. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：437 / 442

页数：6

共 29 条

[11] de Leval X, 2002, EXPERT OPIN THER PAT, V12, P969
[12] Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies
De Simone, G
Di Fiore, A
Menchise, V
Pedone, C
Antel, J
Casini, A
Scozzafava, A
Wurl, M
Supuran, CT
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2315 - 2320
[13] Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II
Di Fiore, A
De Simone, G
Menchise, V
Pedone, C
Casini, A
Scozzafava, A
Supuran, CT
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1937 - 1942
[14] Adverse cardiovascular effects of the coxibs
Dogné, JM
Supuran, CT
Pratico, D
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) : 2251 - 2257
[15] REFINED STRUCTURE OF HUMAN CARBONIC ANHYDRASE-II AT 2.0-A RESOLUTION
ERIKSSON, AE
JONES, TA
LILJAS, A
[J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1988, 4 (04): : 274 - 282
[16] IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS
JONES, TA
ZOU, JY
COWAN, SW
KJELDGAARD, M
[J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 : 110 - 119
[17] KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561
[18] Carbonic anhydrase inhibitors: Stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II
Menchise, V
De Simone, G
Alterio, V
Di Fiore, A
Pedone, C
Scozzafava, A
Supuran, CT
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (18) : 5721 - 5727
[19] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z
Minor, W
[J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 : 307 - 326
[20] Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects
Pastorekova, S
Parkkila, S
Pastorek, J
Supuran, CT
[J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (03) : 199 - 229

← 1 2 3 →